Abstract: The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics.
Type:
Grant
Filed:
August 2, 2018
Date of Patent:
June 6, 2023
Assignees:
Glaxosmithkline Intellectual Property Deveelopment Limited, Massachusetts Institute of Technology
Inventors:
David Lai, Filippos Touriomousis, Andreas Mershin, Neil Gershenfeld